Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Clinical Trial Participants -> Bristol-Myers Squibb Ally 2 Phase III : Recruiting now
Post Info TOPIC: Bristol-Myers Squibb Ally 2 Phase III : Recruiting now
suziq


Senior Member

Status: Offline
Posts: 327
Date:
RE: Bristol-Myers Squibb Ally 2 Phase III : Recruiting now
Permalink  
 

Hi Tig,

You are certainly right about screening for these diseases.  Hepatitis virus has a long life outside the body and requires a very high temp to kill the virus.  I am glad that it is finally getting some public recognition.  Somehow, in our very "open" society, sexual preference and drug addiction/use are still "touchy" subjects for many.  And, unfortunately, that includes some doctors, insurance companies and employers.  Fortunately, now we have some effective drugs to combat both diseases. 

SuziQ  



__________________

Geno 1A  Age 82 Treatment naive Cirrhotic Told I had liver disease in 1966. Diagnosed as Hep C 1999.Started Merck clinical trial with Riba on 9/9/2013 Week 1 and 2 <25  Weeks 4, 8, 12,16,18 UND.  EOT Jan 14,2014  EOT +12 UND   JULY 1 2014 EOT+24= SVR
Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

Hi Susan,

Yes, that is a condition of this trial. I think if all health screenings, annual physicals, etc., included HIV, HBV and HCV screening, society would benefit greatly. With the advances in treatments, I believe we're at a time when significant headway can be made to stop the advancement of these diseases, as well as provide early diagnosis for people that might go decades without knowing they were carrying around a silent killer (HCV). We're seeing great strides made in treatment protocols, I hope we also see as much interest in early education too. It's starting and the new Gilead TV commercials are hopefully a sign of more things to come. 

Tig



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
suziq


Senior Member

Status: Offline
Posts: 327
Date:
Permalink  
 

Hi Tig,

Think you have to be HIV positive as well as have Hep C for that Bristol Meyers trial.  People with HIV are doing very well on the new meds.  There were HIV positive people in my Merck trial.  I was tested for HIV in my screening, I think for both trials I applied for and again during my Merck trial.  It was about as relevant as a pregnancy test--  Been alone for years and I did test in the 80's when HIV first surfaced.  After all, I lived in Los Angeles back then.

SuziQ  



__________________

Geno 1A  Age 82 Treatment naive Cirrhotic Told I had liver disease in 1966. Diagnosed as Hep C 1999.Started Merck clinical trial with Riba on 9/9/2013 Week 1 and 2 <25  Weeks 4, 8, 12,16,18 UND.  EOT Jan 14,2014  EOT +12 UND   JULY 1 2014 EOT+24= SVR
Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

A new phase III trial for HIV/HCV co infection, Ally 2, is currently being recruited. Bristol-Meyers Squibb is the sponsoring manufacturer. Check the included link for additional information. This information was provided by our member "Sara" and I want to thank her for bringing it to our attention!

Tig

http://clinicaltrials.gov/show/NCT02032888



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Clinical Trial Participants -> Bristol-Myers Squibb Ally 2 Phase III : Recruiting now
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.